CVID II Flashcards

1
Q

What are some dysregulated features of T cells in CVID patients that might contribute to their autoimmunity?

A

Decrease in Tregs, increase in Tfh.
reduction in Th17? (Skew more towards Th1?)
STAT3 is downstream of Il-6 and IL-21.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what does APDS stand for? And what are two other syndromes associated with CVID?

A

Activated PI3K delta syndrome. CTLA4 haploinsufficiency and LBRA deficiency.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Is the cause of CVID monogenic or polygenic?

A

Polygenic with a lack of family history ad defects in other systems are abnormal.

Genes identified associated with CVID are unlikely to be causal alone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

deletions and null mutations known to be associated with CVID?

A

deletinos: ICOS

null mutations: CD19, CD20, CD81, IL21/R.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

2 polymorphisms associated with CVID?

A

BAFFR and TACI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

New genes associated with CVID?

A

NFKB1 (haploinsufficiency), PI3K, LRBA and CTLA4.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does NFKB1 encode?

A

Encodes the precursor p105 for NF-kB (p50 and p65 subunits) which are normally sequestered by IkB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does NFKB2 encode?

A

ecnodes p1000 precuros for p52.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What pathways is NF-KB involved in?

A

TLRs TCR, and CD40, OX40, CD27 activation pathways for class switching.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is penetrance like of NFKB1 haploinsufficiency and NFKB2?

A

Low penetrance of symptoms with AD.

NFKB2 has high penetrance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How does NFKB1 differ form NEMO?

A

NEMO assocaited with innate immunodeficiency, no obvious defects in innate immunity in NFKB1.

her you get lymphoma and autoimmunity (varying degrees of hypogammaglubnemia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is switched memory and CD21 levels like in NFB1 haploinsufficiency?

A

low switched memory B cell repsonses and increased CD21lo CD38lo population (only in symptomatic patients)- consistent with autoimmunity and splenamegaly- B cell dyregulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is unusual for NFKB2 as a CVID?

A

more of an early onset.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What pathways is PI3K downstream of? What does this mean for activated PI3Kdelta sydrmoe?

A

More likley not to just affect humoural immunity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what notbable infections does APDS show for a CVID?

A

as well as AI, bronchiesctasis, clymphonma, etheropathay, splenomagaly

Notbaly shows sever herpes virus infections (EBV, CMV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are features of APDS T cells?

A

reduced T cells, but raised CD8 T cells which have a more senescent (CD57+) phenotype.

17
Q

What are B cells like in APDS?

A

low IgG and IgA. IgM may be normal or raised.

More unswitched B cells and transitional B cells

18
Q

What precision treatments are available for APDS patients?

A

siroluimus/rapamycin mTOR inhibitors.

Other PI3K inhbitors (Idelalisib)

19
Q

defining difference in presentation betwen NFKB1 LOF and APDS patients?

A

APDS patients are susceptible to herpesvirus infections. May preform a HSCT for these patients.

20
Q

what is penetrace like for CTLA-4 haploinsufficiency?

A

incomplete pentrance classic immune dysregulation phenotype of AI lymphoproliferation and infections.

21
Q

what targeted therapy might be avaiable for CTLA4 deficiency?

A

Abatacept (engineered fusion protein with CTLA-4 binding domain)

Will sequester B7 (CD80/86).

22
Q

Defining feature of CTLA-4 haploinsufficieny (in common with APDS)?

A

suceptible to herpesvrius infections too.

23
Q

What is the role of LRBA?

A

To rescue CTLA-4 from degradation pathways and get it back to cell surface.

Deficiencies therefore quasi CTLA-4 deficiencies

24
Q

is LRBA AR or AD and what is unusual about it for a CVID?

A

LOF AR and unusally has very early presntaiton (6 months).

25
Q

Do LRBA show evidence of immune dyregulation?

A

Yes, swithced memeory cells are reduced and lymphoma risk as well.

26
Q

What can LRBA be treaed with?

A

abatacecpt.